Future
The Sherman lab is currently open for graduate student lab rotations through the University
Current
David Sherman, PhD
|
David Sherman is a Professor and Department Chair of the Department of Microbiology in the University of Washington School of Medicine in Seattle. He earned his PhD in Biochemistry from Vanderbilt University, and performed post-graduate work at the Rockefeller University and at Washington University in St. Louis. His laboratory studies the molecular genetics, systems biology and pathogenesis of M. tuberculosis, and is also engaged in drug discovery efforts for this important pathogen. Dr. Sherman played a lead role in the discovery and early development of the anti-TB agent pretomanid. In addition, his laboratory defined the mutation responsible for attenuation of the world’s most widely used vaccine, BCG. On a personal level, Dr. Sherman routinely leaps tall buildings in a single bound and completes 60-minute gourmet recipes in under 40 minutes. Children and dogs love him. He is far too modest to take pleasure from the fact that you are reading about him right now.
|
|
Kristin Adams, PhD
|
Mark Jones, PhD
|
Mark Jones is an acting instructor in the Sherman Lab. He previously earned his PhD from the University of Georgia and trained as a postdoc at the Johns Hopkins Bloomberg School of Public Health. His microbial pursuits have been centered around the exploration of host-microbe interactions, working with the squid-Vibrio model system, enteric pathogens, and now mycobacterial infection. Outside of the lab, Mark enjoys cooking, fermenting, hiking, and paddling.
|
I have always been intrigued by the promiscuous nature of the small chemical compounds and their astonishing ability to produce multiple off target effects. Potentially, these interactions can be exploited to attain desirable clinical outcomes in treating persistent microbial infections. During my PhD (Purdue University), I focused my research primarily on repurposing FDA-approved drugs to overcome drug resistance mechanisms in emerging Candida species. My current work in Sherman’s lab employs a similar strategy to fight against the deadly mycobacterial infections and to uncover novel drugs and drug targets.
|
Hassan Eldesouky, PhD
Post-Doctoral Fellow |
José Manuel Ezquerra-Aznárez
|
|
|
Eleanor Lamont
Graduate Student elamont@uw.edu
|
Laarni Aguila
|
|
Lance Fredericks
|
Jessica Assadi
|
|
|
Justin Brache
Research Scientist Engineer I |
Anna Pruneda
Undergraduate Assistant |
|